Vivos Therapeutics, Inc. (VVOS) — Institutional Holders, Q2 2026
23 institutional investment managers reported a VVOS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $242.9K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
VVOS in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTNew · +60,629 sh+$27.6K
- IHT Wealth ManagementAdded · +35,675 sh+$16.2K
- UBS Group AGAdded · +28,108 sh+$12.8K
- VANGUARD FIDUCIARYNew · +23,432 sh+$10.7K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +10,075 sh+$4.6K
Biggest sellers
- ARMISTICE CAPITALSold out · -1,115,859 sh-$507.2K
- XTX Topco LtdSold out · -25,117 sh-$11.4K
- GEODE CAPITAL MANAGEMENTTrimmed · -10,542 sh-$4.8K
- Tower Research Capital (TRC)Trimmed · -2,177 sh-$989.00
- NORTHWESTERN MUTUAL WEALTH MANAGEMENTSold out · -3 sh-$1.00
VVOS 13F holders ranked 1–23 of 23
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT#1 · 85,001 sh | 85,001 | $38.6K | 0.00% | -11.0% |
| 2 | IHT Wealth Management#2 · 76,736 sh | 76,736 | $34.9K | <0.01% | +86.9% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 60,629 sh | 60,629 | $27.6K | 0.00% | New |
| 4 | COMMONWEALTH EQUITY SERVICES#4 · 42,500 sh | 42,500 | $19.3K | 0.00% | 0.0% |
| 5 | B. Riley Wealth Advisors#5 · 38,066 sh | 38,066 | $18.8K | — | 0.0% |
| 6 | UBS Group AG#6 · 39,154 sh | 39,154 | $17.8K | 0.00% | +254.5% |
| 7 | Centurion Wealth Management#7 · 35,684 sh | 35,684 | $16.2K | — | 0.0% |
| 8 | BlackRock#8 · 27,817 sh | 27,817 | $12.6K | 0.00% | 0.0% |
| 9 | STATE STREET#9 · 24,922 sh | 24,922 | $11.3K | 0.00% | 0.0% |
| 10 | Sequoia Financial Advisors#10 · 24,000 sh | 24,000 | $10.9K | <0.01% | 0.0% |
| 11 | VANGUARD FIDUCIARY#11 · 23,432 sh | 23,432 | $10.7K | 0.00% | New |
| 12 | NORTHERN#12 · 20,775 sh | 20,775 | $9.4K | 0.00% | +66.1% |
| 13 | Acorn Wealth Advisors#13 · 14,776 sh | 14,776 | $6.7K | — | 0.0% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#14 · 10,075 sh | 10,075 | $4.6K | 0.00% | New |
| 15 | Tower Research Capital (TRC)#15 · 5,211 sh | 5,211 | $2.4K | <0.01% | -29.5% |
| 16 | OSAIC#16 · 1,143 sh | 1,143 | $516.00 | 0.00% | 0.0% |
| 17 | SIGNATUREFD#17 · 547 sh | 547 | $249.00 | — | 0.0% |
| 18 | Integrated Wealth Concepts#18 · 320 sh | 320 | $144.00 | 0.00% | New |
| 19 | Ronald Blue#19 · 160 sh | 160 | $73.00 | — | 0.0% |
| 20 | Kozak & Associates#20 · 49 sh | 49 | $24.00 | 0.00% | 0.0% |
| 21 | Global Retirement Partners#21 · 23 sh | 23 | $10.00 | 0.00% | — |
| 22 | MORGAN STANLEY#22 · 7 sh | 7 | $3.00 | 0.00% | 0.0% |
| 23 | ROYAL BANK OF CANADA#23 · 4 sh | 4 | $0.00 | 0.00% | 0.0% |
Funds that sold out of VVOS in Q2 2026 (4)
Held VVOS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| ARMISTICE CAPITAL1,115,859 sh | 1,115,859 | $1.3M |
| XTX Topco Ltd25,117 sh | 25,117 | $29.6K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT3 sh | 3 | $4.00 |
| CITIGROUP1 sh | 1 | $1.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.